Allarity Therapeutics, Inc. (ALLR): Total Assets
$18.26M
As of 2025-12-31
$32.12M
As of 2026-06-30
+7.9%
3-year compound annual growth
-11.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.26M | -19.4% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $22.65M | +90.9% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $11.86M | -18.4% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $14.54M | -70.7% | 2024-03-08, Balance as of period end |
| 2021-12-31 | $49.63M | +48.6% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $33.40M | n/a | 2022-05-17, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $18.26M | -19.4% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $6.50M | +370.3% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $697.5K | -30.7% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $21.06M | +179.3% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $9.51M | +4.3% |
| Medicinova Inc (MNOV) | 2025-12-31 | $45.60M | -18.4% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $84.18M | -19.7% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $274.6K | +70.5% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $45.92M | -39.9% |
Compare ALLR, HIND, PVCT, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗